The role of parental preferences in the management of fever without source among 3- to 36-month-old children

A decision analysis

Kristine A. Madsen, Jonathan E. Bennett, Stephen Downs

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

OBJECTIVES. Recent analyses assessing the impact of the conjugate pneumococcal vaccine on the care of febrile children do not reflect the role parental preferences play in physicians' decisions. The objective of this study was to identify the management strategy that would best suit parents, on the basis of their values for possible outcomes of fever of ≥39°C without source among well-appearing, 3- to 36-month-old children. METHODS.A decision analysis was performed to compare the benefits and outcomes of 3 management options (treat: blood culture and antibiotics for all children; test: blood culture and complete blood count for all children, with antibiotics for selected children; observe: no immediate intervention). A hypothetical cohort of 100 000 children with fever of ≥39°C with no obvious source of infection was modeled for each strategy. Using this model, we identified the treatment option that would best suit each parent's preferences, on the basis of parental utilities (from a prior study) for various interventions and outcomes at vaccine efficacies of 0% (ie, no vaccine) and 95%. In addition, we performed survival analyses to assess the morbidity and mortality rates associated with each treatment strategy at various vaccine efficacies. RESULTS. At a vaccine efficacy of 0%, the majority of parents' preferences suggested the treat option, the strategy with the lowest mortality rate. At a vaccine efficacy of 95%, mortality rates were similar for all 3 management options (∼1 in 100 000), but parental preferences were still aligned with different options; 50% suggested observe, 42% suggested test, and 8% suggested treat. CONCLUSIONS. Like physicians, parents have different approaches to risk. With the conjugate pneumococcal vaccine, risks of complications from fever without source are low regardless of treatment strategy. Rather than having a "one size fits all" approach, it is reasonable to incorporate parental preferences into the treatment decision.

Original languageEnglish (US)
Pages (from-to)1067-1076
Number of pages10
JournalPediatrics
Volume117
Issue number4
DOIs
StatePublished - 2006

Fingerprint

Decision Support Techniques
Fever
Vaccines
Parents
Conjugate Vaccines
Pneumococcal Vaccines
Mortality
Anti-Bacterial Agents
Physicians
Blood Cell Count
Therapeutics
Survival Analysis
Child Care
Morbidity
Infection

Keywords

  • Child
  • Decision-making
  • Fever of unknown origin
  • Parental attitudes
  • Patient-doctor communication

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

The role of parental preferences in the management of fever without source among 3- to 36-month-old children : A decision analysis. / Madsen, Kristine A.; Bennett, Jonathan E.; Downs, Stephen.

In: Pediatrics, Vol. 117, No. 4, 2006, p. 1067-1076.

Research output: Contribution to journalArticle

@article{cb459c66b8b943aa98dfdbec72254051,
title = "The role of parental preferences in the management of fever without source among 3- to 36-month-old children: A decision analysis",
abstract = "OBJECTIVES. Recent analyses assessing the impact of the conjugate pneumococcal vaccine on the care of febrile children do not reflect the role parental preferences play in physicians' decisions. The objective of this study was to identify the management strategy that would best suit parents, on the basis of their values for possible outcomes of fever of ≥39°C without source among well-appearing, 3- to 36-month-old children. METHODS.A decision analysis was performed to compare the benefits and outcomes of 3 management options (treat: blood culture and antibiotics for all children; test: blood culture and complete blood count for all children, with antibiotics for selected children; observe: no immediate intervention). A hypothetical cohort of 100 000 children with fever of ≥39°C with no obvious source of infection was modeled for each strategy. Using this model, we identified the treatment option that would best suit each parent's preferences, on the basis of parental utilities (from a prior study) for various interventions and outcomes at vaccine efficacies of 0{\%} (ie, no vaccine) and 95{\%}. In addition, we performed survival analyses to assess the morbidity and mortality rates associated with each treatment strategy at various vaccine efficacies. RESULTS. At a vaccine efficacy of 0{\%}, the majority of parents' preferences suggested the treat option, the strategy with the lowest mortality rate. At a vaccine efficacy of 95{\%}, mortality rates were similar for all 3 management options (∼1 in 100 000), but parental preferences were still aligned with different options; 50{\%} suggested observe, 42{\%} suggested test, and 8{\%} suggested treat. CONCLUSIONS. Like physicians, parents have different approaches to risk. With the conjugate pneumococcal vaccine, risks of complications from fever without source are low regardless of treatment strategy. Rather than having a {"}one size fits all{"} approach, it is reasonable to incorporate parental preferences into the treatment decision.",
keywords = "Child, Decision-making, Fever of unknown origin, Parental attitudes, Patient-doctor communication",
author = "Madsen, {Kristine A.} and Bennett, {Jonathan E.} and Stephen Downs",
year = "2006",
doi = "10.1542/peds.2005-1865",
language = "English (US)",
volume = "117",
pages = "1067--1076",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "4",

}

TY - JOUR

T1 - The role of parental preferences in the management of fever without source among 3- to 36-month-old children

T2 - A decision analysis

AU - Madsen, Kristine A.

AU - Bennett, Jonathan E.

AU - Downs, Stephen

PY - 2006

Y1 - 2006

N2 - OBJECTIVES. Recent analyses assessing the impact of the conjugate pneumococcal vaccine on the care of febrile children do not reflect the role parental preferences play in physicians' decisions. The objective of this study was to identify the management strategy that would best suit parents, on the basis of their values for possible outcomes of fever of ≥39°C without source among well-appearing, 3- to 36-month-old children. METHODS.A decision analysis was performed to compare the benefits and outcomes of 3 management options (treat: blood culture and antibiotics for all children; test: blood culture and complete blood count for all children, with antibiotics for selected children; observe: no immediate intervention). A hypothetical cohort of 100 000 children with fever of ≥39°C with no obvious source of infection was modeled for each strategy. Using this model, we identified the treatment option that would best suit each parent's preferences, on the basis of parental utilities (from a prior study) for various interventions and outcomes at vaccine efficacies of 0% (ie, no vaccine) and 95%. In addition, we performed survival analyses to assess the morbidity and mortality rates associated with each treatment strategy at various vaccine efficacies. RESULTS. At a vaccine efficacy of 0%, the majority of parents' preferences suggested the treat option, the strategy with the lowest mortality rate. At a vaccine efficacy of 95%, mortality rates were similar for all 3 management options (∼1 in 100 000), but parental preferences were still aligned with different options; 50% suggested observe, 42% suggested test, and 8% suggested treat. CONCLUSIONS. Like physicians, parents have different approaches to risk. With the conjugate pneumococcal vaccine, risks of complications from fever without source are low regardless of treatment strategy. Rather than having a "one size fits all" approach, it is reasonable to incorporate parental preferences into the treatment decision.

AB - OBJECTIVES. Recent analyses assessing the impact of the conjugate pneumococcal vaccine on the care of febrile children do not reflect the role parental preferences play in physicians' decisions. The objective of this study was to identify the management strategy that would best suit parents, on the basis of their values for possible outcomes of fever of ≥39°C without source among well-appearing, 3- to 36-month-old children. METHODS.A decision analysis was performed to compare the benefits and outcomes of 3 management options (treat: blood culture and antibiotics for all children; test: blood culture and complete blood count for all children, with antibiotics for selected children; observe: no immediate intervention). A hypothetical cohort of 100 000 children with fever of ≥39°C with no obvious source of infection was modeled for each strategy. Using this model, we identified the treatment option that would best suit each parent's preferences, on the basis of parental utilities (from a prior study) for various interventions and outcomes at vaccine efficacies of 0% (ie, no vaccine) and 95%. In addition, we performed survival analyses to assess the morbidity and mortality rates associated with each treatment strategy at various vaccine efficacies. RESULTS. At a vaccine efficacy of 0%, the majority of parents' preferences suggested the treat option, the strategy with the lowest mortality rate. At a vaccine efficacy of 95%, mortality rates were similar for all 3 management options (∼1 in 100 000), but parental preferences were still aligned with different options; 50% suggested observe, 42% suggested test, and 8% suggested treat. CONCLUSIONS. Like physicians, parents have different approaches to risk. With the conjugate pneumococcal vaccine, risks of complications from fever without source are low regardless of treatment strategy. Rather than having a "one size fits all" approach, it is reasonable to incorporate parental preferences into the treatment decision.

KW - Child

KW - Decision-making

KW - Fever of unknown origin

KW - Parental attitudes

KW - Patient-doctor communication

UR - http://www.scopus.com/inward/record.url?scp=33646379610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646379610&partnerID=8YFLogxK

U2 - 10.1542/peds.2005-1865

DO - 10.1542/peds.2005-1865

M3 - Article

VL - 117

SP - 1067

EP - 1076

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 4

ER -